Morse Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.58M Sell
10,287
-174
-2% -$77.5K 1% 31
2025
Q1
$5.07M Sell
10,461
-94
-0.9% -$45.6K 1.28% 26
2024
Q4
$4.25M Buy
10,555
+578
+6% +$233K 0.97% 27
2024
Q3
$4.64M Sell
9,977
-138
-1% -$64.2K 1% 26
2024
Q2
$4.74M Sell
10,115
-80
-0.8% -$37.5K 1.15% 28
2024
Q1
$4.26M Buy
10,195
+706
+7% +$295K 1.09% 33
2023
Q4
$3.86M Buy
9,489
+1,547
+19% +$629K 1.14% 32
2023
Q3
$2.76M Buy
7,942
+621
+8% +$216K 0.87% 39
2023
Q2
$2.58M Buy
7,321
+1,425
+24% +$501K 0.78% 42
2023
Q1
$1.86M Buy
5,896
+681
+13% +$215K 0.63% 52
2022
Q4
$1.51M Buy
5,215
+1,278
+32% +$369K 0.55% 57
2022
Q3
$1.14M Buy
3,937
+2,105
+115% +$610K 0.43% 67
2022
Q2
$516K Buy
1,832
+375
+26% +$106K 0.17% 109
2022
Q1
$380K Buy
+1,457
New +$380K 0.09% 139
2021
Q1
Sell
-1,268
Closed -$300K 163
2020
Q4
$300K Sell
1,268
-9,710
-88% -$2.3M 0.08% 118
2020
Q3
$2.99M Buy
10,978
+2,411
+28% +$656K 0.96% 28
2020
Q2
$2.49M Buy
8,567
+4,837
+130% +$1.4M 0.89% 33
2020
Q1
$888K Buy
3,730
+2,419
+185% +$576K 0.42% 56
2019
Q4
$287K Buy
+1,311
New +$287K 0.1% 113
2019
Q3
Sell
-9,628
Closed -$1.77M 142
2019
Q2
$1.77M Sell
9,628
-2,880
-23% -$528K 0.52% 56
2019
Q1
$2.3M Buy
12,508
+6,795
+119% +$1.25M 0.69% 45
2018
Q4
$947K Sell
5,713
-10,102
-64% -$1.67M 0.34% 70
2018
Q3
$3.05M Buy
15,815
+9,764
+161% +$1.88M 0.8% 40
2018
Q2
$1.03M Buy
6,051
+675
+13% +$115K 0.28% 83
2018
Q1
$876K Buy
5,376
+46
+0.9% +$7.5K 0.24% 86
2017
Q4
$799K Buy
5,330
+180
+3% +$27K 0.22% 87
2017
Q3
$783K Buy
+5,150
New +$783K 0.23% 86